← SynDRA
JNJ-7706621
SynDRA canonical compound SYN0005815 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | CDK1 |
|---|
| Mechanism of action | CDK inhibitor |
|---|
All known targets
- CDK1
- CDK2
- AURKA
- AURKB
- JAK2
Mechanisms of action (all sources)
- cyclin-dependent kinase inhibitor
- AURKA INHIBITOR
- AURKB INHIBITOR
- CDK1 INHIBITOR
- CDK2 INHIBITOR
- JAK2 BINDER
- JAK2 INHIBITOR
Cross-references
Synonyms
- JNJ 7706621
- JNJ7706621
- 4-((5-Amino-1-(2,6-difluorobenzoyl)-1H-1,2,4-triazol-3-yl)amino)benzenesulfonamide
- UNII-74GK72DON8
- RWJ-387252
- 4-[[5-amino-1-(2,6-difluorobenzoyl)-1,2,4-triazol-3-yl]amino]benzenesulfonamide
- CHEMBL191003
- 74GK72DON8
- 4-[[5-Amino-1-(2,6-difluorobenzoyl)-1H-1,2,4-triazol-3-yl]amino]benzenesulfonamide
- 4-(5-amino-1-(2,6-difluorobenzoyl)-1H-1,2,4-triazol-3-ylamino)benzenesulfonamide
- Aurora Kinase/Cdk Inhibitor
- JNJ-770662
- RefChem:150556
- DTXCID70367056
- MFCD11100270
- C15H12F2N6O3S
- 3ama
- KDKUVYLMPJIGKA-UHFFFAOYSA-N
- SKE
- Kinome_3748
- MLS006011037
- BDBM6866
- GTPL5932
- orb1301051
- SCHEMBL1060773
- CHEBI:94506
- cid_5330790
- GLXC-90017
- HMS3244O15
- HMS3244O16
- HMS3244P15
- HMS3654J07
- EX-A1979
- s1249
- AKOS016009412
- CCG-264878
- CS-0179
- SB19461
Look up JNJ-7706621 in the interactive SynDRA portal →